Trial Profile
Phase II Study of JNS024PR in Cancer Pain Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2013
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 10 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jun 2009 Planned end date changed from May 2009 to Jul 2009 as reported by ClinicalTrials.gov.